Milan, Italy

Monique Sarret

This inventor holds 1 USPTO granted patent. Top assignee: Italfarmaco Spa. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Monique Sarret. Retrieved from https://idiyas.com/inventor/monique-sarret

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Monique Sarret: Innovator in Pharmaceutical Compositions

Introduction

Monique Sarret is a notable inventor based in Milan, Italy. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on glycosaminoglycan salts.

Latest Patents

Monique holds a patent for "Glycosaminoglycan salts and pharmaceutical compositions containing them." This patent highlights her expertise in developing pharmaceutical compositions that can have a profound impact on medical treatments.

Career Highlights

Monique Sarret is currently employed at Italfarmaco Spa, where she continues to advance her research and development efforts. Her work at this esteemed company has positioned her as a key player in the pharmaceutical industry.

Collaborations

Monique collaborates with talented professionals such as Alma Dal Pozzo and Maurizio Acquasaliente. These partnerships enhance her research and contribute to the innovative projects at Italfarmaco Spa.

Conclusion

Monique Sarret's contributions to pharmaceutical innovations exemplify her dedication to improving healthcare through her inventions. Her work continues to inspire and pave the way for future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…